Rheumatic heart disease and its control in the Pacific

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 12, 2009, Pages 1517-1524

  Colquhoun, Samantha M ^a,b   Carapetis, Jonathan R ^a   Kado, Joseph H ^c   Steer, Andrew C ^b,d  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Fiji Ministry of Health   (Fiji)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acute rheumatic fever; Developing countries; Epidemiology; Pacific islands; Rheumatic heart disease

Indexed keywords

BENZATHINE PENICILLIN; STREPTOCOCCUS VACCINE;

DISEASE CONTROL; ECHOCARDIOGRAPHY; GROUP A STREPTOCOCCAL INFECTION; HEALTH CARE COST; HEALTH DISPARITY; HEALTH PROMOTION; HEART MURMUR; HEART VALVE REPLACEMENT; HUMAN; IMPETIGO; INDIGENOUS PEOPLE; MASS SCREENING; PACIFIC ISLANDS; PORTABLE EQUIPMENT; PREVALENCE; PRIMARY PREVENTION; PUBLIC HEALTH PROBLEM; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCAL PHARYNGITIS;

ACUTE DISEASE; HUMANS; PACIFIC ISLANDS; PREVALENCE; PRIMARY PREVENTION; REGISTRIES; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION;

EID: 73349093770     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.145     Document Type: Review

References (67)

1. WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation, Geneva, 29 October-1 November 2001. WHO Technical Report Series 923. WHO, Geneva, Switzerland (2003).
2. Carapetis JR. Rheumatic heart disease in developing countries. N. Engl. J. Med. 357(5), 439-441 (2007).
3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5(11), 685-694 (2005).
4. Secretariat of the Pacific Community (SPC) Statistics and Demography division. Population and Demographic indicators. Complication of regional government population statistics (2009).
5. World Bank Statistics. World Bank, DC, USA (2009).
6. Negus RM. Rheumatic fever in Western Fiji: the female preponderence. Med. J. Aust. 2, 251-254 (1971).
7. Neutze JM. Rheumatic fever and rheumatic heart disease in the western Pacific region. NZ Med. J. 101, 404-406 (1988).
8. Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J. Paediatr. Child Health 38, 229-234 (2002).
9. Steer AC, Kado J, Wilson N et al. High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J. Heart Valve Dis. 18, 327-335 (2009).
10. Carapetis JR, Hardy M, Fakakovikaetau T et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect aysmtomatic rheumatic heart disease in Tongan school children. Nature Clin. Prac. Cardiovasc. Med. 5(7), 411-417 (2008).
11. Steer AC, Kado J, Jenney AW et al. Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007. Med. J. Aust. 190, 133-135 (2009).
12. Bishop W, Currie B, Carapetis J, Kilburn C. A subtle presentation of acute rheumatic fever in remote northern Australia. Aust. NZ J. Med. 26, 241-242 (1996).
13. Parks T, Kado J, Colquhoun S, Carapetis J, Steer A. Underdiagnosis of acute rhuematic fever in primary care settings in a developing country. Trop. Med. Int. Health 14(11), 1407-1413 (2009).
14. Jaine R, Baker M, Venugopal K. Epidemiology of acute rheumatic fever in New Zealand 1996-2005. J. Paediatr. Child Health 44, 564-571 (2008).
15. Chun LT, Reddy DV, Yim GK, Yamamoto LG. Acute rheumatic fever in Hawaii: 1966 to 1988. Hawaii Med. J. 51, 206-211 (1992).
16. Erdem G, Dodd A, Tuua A et al. Acute rheumatic fever in American Samoa. Pediatr. Infect. Dis. J. 26(12) 1158-1159 (2007).
17. Reeves B, Kado J, Brook M. Rapid echocardiographic screening for rheumatic heart disease in Fiji. Presented at: The Australian Heart Foundation Conference. Brisbane, Australia, 14-16 May 2009.
18. Viali S. Rheumatic fever and rheumatic heart disease in Samoa. Pac. Health Dialog 13(2), 31-38 (2006).
19. World Heart Federation. Fiji Rheaumatic Heart Disease National Register Data. World Health Federation, Geneva, Switzerland (2009).
20. WHO. Pacific RHD. Presented at: WHO & WHF Pacific RHD Workshop. Nadi, Fiji, 13-15 February 2006.
21. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst. Rev. 4, CD000023 (2000).
22. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA. Prevention of rheumatic fever; treatment of preceding streptococci infection. JAMA 143, 151-153 (1950).
23. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc. Disorders 31(5), 11 (2005).
24. Stollerman GH, Rusoff JH, Hirschfeld I. Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G. N. Engl. J. Med. 252, 787-792 (1955).
25. Tompkins DG, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45, 543-551 (1972).
26. Lennon D, Kerdemelidis M, Arroll B. Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever. Pediatr. Infect. Dis. J. 28(7), E259-E264 (2009).
27. Phibbs B, Taylor J, Zimmerman RA. A community-wide streptococcal control project. The Natrona County Primary Prevention Program, Casper, Wyo. JAMA 214, 2018-2024 (1970).
28. Coulehan JL, Baacke G, Welty TK, Goldtooth NL. Cost-benefit of a streptococcal surveillance program among Navajo Indians. Public Health Rep. 97, 73-77 (1982).
29. Lennon D, Stewart J, Farrell E, Palmer A, Mason H. School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand. Pediatr. Infect. Dis. J. 28(9), 787-794 (2009).
30. Strategy for controlling rheumatic fever/ rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting. Bull. World Health Org. 73, 583-587 (1995).
31. Strasser T. Cost-effective control of rheumatic fever in the community. Health Policy 5, 159-164 (1985).
32. McDonald M, Brown A, Noonan S, Carapetis JR. Preventing rheumatic fever: the role of register based programmes. Heart 91, 1131-1133 (2005).
33. Vendsborg P, Hansen LF, Olesen KH. Decreasing incidence of a history of acute rheumatic fever in chronic rheumatic heart disease. Cardiologia 53, 332-340 (1968).
34. Bisno AL, Rubin FA, Cleary PP et al. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles - report of a National Institute of Allergy and Infectious Diseases workshop. Clin. Infect. Dis. 41(8), 1150-1156 (2005).
35. Carapetis JR. A review of WHO activities. In: The Burden of, and the Evidence for Strategies to Control Group A Streptococcal Diseases: part 4: a Review of the Technical Basis for the Current WHO Approach to the Control of Conditions Associated with GAS Infections. WHO, Geneva, Switzerland, 1-46 (2004).
36. MacDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect. Dis. 4, 240-245 (2004).
37. Kaplan EL, Bisno AL. Antecedent streptococcal infection in acute rheumatic fever. Clin. Infect. Dis. 43(6), 690-692 (2006).
38. Strasser T, Dondog N, El Kholy A et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull. World Health Organ. 59(2), 285-294 (1981).
39. Rheumatic fever and rheumatic heart disease. Report of a WHO study group. World Health Organ. Tech. Rep. Ser. 764, 1-58 (1988).
40. WHO. Prevention in childhood and youth of adult cardiovascular diseases, time for action. In: WHO Technical Report Series. WHO, Geneva, Switzerland (1990).
41. WHO. Community prevention and control of cardiovascular diseases, report of a WHO Expert committee In: WHO Technical Report Series. WHO, Geneva, Switzerland (1986).
42. WHO. WHO Global Program for the Prevention of Rheumatic Fever/Rheumatic Heart Disease in Sixteen Developing Countries (AGFUND Supported). Meeting of National Program Managers. WHO, Geneva, Switzerland (1987).
43. WHO, CD Unit. WHO program for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from phase 1 (1986-1990). Bull. World Health Organ. 70(2), 213-218 (1992).
44. WHO. The WHO Global Program for the Prevention of Rheumatic Fever and Rheumatic Heart Disease: Report of a Consultation to Review Progress and Develop Future Activities. WHO, Geneva, Switzerland, 1-49 (2000).
45. Bach JF, Chalons S, Forier E et al. 10-year educational program aimed at rheumatic fever in two French Caribbean islands. Lancet 347, 644-648 (1996).
46. Thornley C, McNicholas A, Baker M. Rheumatic fever registers in New Zealand, in streptococci and streptococcal diseases entering the new millennium. Martin DR, Tagg JR (Eds). ESR, Porirua, New Zealand, 541-543 (2000).
47. Roxon N, Macklin J. Closing the Gap in Indiegnous Health. Australian Department of Health and Ageing, Canberra, Australia (2008).
48. Steer AC, Kado J, Colquhoun S, Noonan S, Babitu T. Awareness of rheumatic heart disease. Lancet 367(9528), 2118 (2006).
49. WHO. Rheumatic Fever and Rheumatic Heart Disease: WHO Technical Report Series. WHO, Geneva, Switzerland, 122 (2004).
50. Carapetis JR. Rheumatic heart disease in developing countries. N. Engl. J. Med. 357(5), 439-441 (2007).
51. Carapetis JR. Pediatric rheumatic heart disease in the developing world: echocardiographic versus clinical screening. Nat. Clin. Prac. Cardiovasc. Med. 5(2), 74-75 (2008).
52. Marijon E, Ou P, Celermajer DS et al. Prevelance of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470-476 (2007).
53. Marijon E, Celermajer DS, Tafflet M et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 38(2), 375-385 (2009).
54. Marijon E, Ou P, Celermajer DS et al. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ. 86(2), 84 (2008).
55. Feikin DR, Nelson CB, Watt JP, Mohsni E, Wenger JD, Levine OS. Rapid Assessment Tool for Haemophilus influenzae type b disease in developing countries. Emerg. Infect. Dis. 10, 1270-1276 (2004).
56. Campagne dépistage échographique de valvulopathies post rhumatismales. Agence de Sociate et Sanitaire de Nouvelle Caledonie, Noumea, France (2007).
57. Steer AC, Adams J, Carlin J, Nolan T, Shann F. Rheumatic heart disease in school children in Samoa. Arch. Dis. Child 81(4), 372 (1999).
58. Finau SA, Taylor L. Rheumatic heart disease and school screening: initiatives at an isolated hospital in Tonga. Med. J. Aust. 148, 563-567 (1988).
59. Alto W. Rheumatic fever in Micronesia. Pacific Health Dialogue 1, 13-18 (1992).
60. Australian Institute of Health and Welfare, Field B. Rheumatic heart disease: all but forgotten in Australia except among Aboriginal and Torres Strait Islander people. Aust. Institute Health Welfare 16(48), 1-20 (2004).
61. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med. J. Aust. 164, 146-149 (1996).
62. Neilson G, Streatfield RW, West M, Johnson S, Glavin W, Baird S. Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Establishment of a prophylactic program. Med. J. Aust. 158, 316-318 (1993).
63. Brennan RE, Patel MS. Acute rheumatic fever and rheumatic heart disease in a rural central Australian aboriginal community. Med. J. Aust. 153, 335; 338-339 (1990).
64. SPC. Secretariat of the Pacific Community: Population and Demographic indicators. 2009 www.spc.int/sdp/index.php?option=com-frontpage&Itemid=1].
65. Pacific Rheumatic Heart Disease Call to Action (2008) www.world-heart-federation.org/what-wedo/ demonstration-projects/rheumaticheart- disease-demonstration-projects/ pacific-islands/]
66. Rhumatisme articulaire aigu (RAA) 2009 www.ass.nc/index.php?option=com- content&task=view&id=81&Itemid=14
67. RHDnet. 2009 www.world-heart-federation.org/about-us/ scientific-advisory-board/rheumatic-heartdisease-network/